| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | semaphorin receptor activity | 1.73e-06 | 12 | 157 | 4 | GO:0017154 | |
| GeneOntologyMolecularFunction | acetylspermidine deacetylase activity | 6.14e-05 | 2 | 157 | 2 | GO:0047611 | |
| GeneOntologyCellularComponent | semaphorin receptor complex | 2.18e-06 | 13 | 159 | 4 | GO:0002116 | |
| Domain | Plexin_cytopl | 5.57e-07 | 9 | 155 | 4 | PF08337 | |
| Domain | Plexin_cytoplasmic_RasGAP_dom | 5.57e-07 | 9 | 155 | 4 | IPR013548 | |
| Domain | Plexin | 5.57e-07 | 9 | 155 | 4 | IPR031148 | |
| Domain | IPT | 6.90e-05 | 27 | 155 | 4 | SM00429 | |
| Domain | - | PLXNA3 TAF1C WDR27 WDFY4 HIRA PLXNA4 IFT122 DCAF4 PLXNA2 PLXNB1 NSMAF | 1.08e-04 | 333 | 155 | 11 | 2.130.10.10 |
| Domain | WD40/YVTN_repeat-like_dom | PLXNA3 TAF1C WDR27 WDFY4 HIRA PLXNA4 IFT122 DCAF4 PLXNA2 PLXNB1 NSMAF | 1.14e-04 | 335 | 155 | 11 | IPR015943 |
| Domain | Semap_dom | 1.21e-04 | 31 | 155 | 4 | IPR001627 | |
| Domain | SEMA | 1.21e-04 | 31 | 155 | 4 | PS51004 | |
| Domain | TIG | 1.21e-04 | 31 | 155 | 4 | PF01833 | |
| Domain | Sema | 1.21e-04 | 31 | 155 | 4 | SM00630 | |
| Domain | Sema | 1.21e-04 | 31 | 155 | 4 | PF01403 | |
| Domain | IPT | 1.37e-04 | 32 | 155 | 4 | IPR002909 | |
| Domain | Plexin_repeat | 1.37e-04 | 32 | 155 | 4 | IPR002165 | |
| Domain | PSI | 1.37e-04 | 32 | 155 | 4 | PF01437 | |
| Domain | PSI | 4.78e-04 | 44 | 155 | 4 | IPR016201 | |
| Domain | PSI | 5.68e-04 | 46 | 155 | 4 | SM00423 | |
| Pathway | REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION | 3.65e-05 | 9 | 109 | 3 | MM15030 | |
| Pathway | REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION | 1.54e-04 | 14 | 109 | 3 | MM15029 | |
| Pathway | REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION | 1.54e-04 | 14 | 109 | 3 | M7578 | |
| Pathway | REACTOME_CRMPS_IN_SEMA3A_SIGNALING | 1.91e-04 | 15 | 109 | 3 | MM15031 | |
| Pathway | REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION | 2.34e-04 | 16 | 109 | 3 | M16498 | |
| Pathway | REACTOME_CRMPS_IN_SEMA3A_SIGNALING | 2.34e-04 | 16 | 109 | 3 | M8245 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ALKBH4 PLXNA3 FRAS1 ABCA2 SHISA5 MUS81 PPP6R1 TRRAP MADD HIRA TYK2 KMT2C PNPLA6 MROH1 PTPRS ZNF335 USP40 ZNF839 DNMBP IL4R FOXK1 WNK2 HTT | 1.85e-09 | 1105 | 161 | 23 | 35748872 |
| Pubmed | 8.37e-09 | 16 | 161 | 5 | 17356169 | ||
| Pubmed | 3.05e-08 | 8 | 161 | 4 | 15661641 | ||
| Pubmed | 5.47e-08 | 9 | 161 | 4 | 19909241 | ||
| Pubmed | Transmembrane semaphorin signalling controls laminar stratification in the mammalian retina. | 2.13e-07 | 12 | 161 | 4 | 21270798 | |
| Pubmed | 3.06e-07 | 13 | 161 | 4 | 10520995 | ||
| Pubmed | 3.88e-07 | 4 | 161 | 3 | 11306810 | ||
| Pubmed | PlexinA polymorphisms mediate the developmental trajectory of human corpus callosum microstructure. | 3.88e-07 | 4 | 161 | 3 | 25518740 | |
| Pubmed | A family of transmembrane proteins with homology to the MET-hepatocyte growth factor receptor. | 3.88e-07 | 4 | 161 | 3 | 8570614 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | NSUN5P1 FAM53A WDR27 TRRAP TYK2 BPTF KMT2C CFAP20DC USF3 CMIP PNPLA6 GPR137C PTPRS USP40 CHD6 IFT122 ANKRD12 ZNF839 CLEC16A DAGLA WNK2 NSMAF HTT | 4.17e-07 | 1489 | 161 | 23 | 28611215 |
| Pubmed | FRAS1 PPP6R1 CSMD3 MADD MROH1 STARD9 NAV3 TCF25 CHD6 ANKRD12 CLEC16A PLXNA2 | 4.88e-07 | 407 | 161 | 12 | 12693553 | |
| Pubmed | 1.00e-06 | 17 | 161 | 4 | 11683995 | ||
| Pubmed | Semaphorin signaling facilitates cleft formation in the developing salivary gland. | 1.00e-06 | 17 | 161 | 4 | 17626059 | |
| Pubmed | ABCA2 ZFYVE28 KMT2C SULF2 NRXN3 FBXL7 ABCA5 CNTNAP2 CARNS1 DNMBP DAGLA WNK2 PLXNB1 | 1.24e-06 | 529 | 161 | 13 | 14621295 | |
| Pubmed | Semaphorin-6A controls guidance of corticospinal tract axons at multiple choice points. | 3.36e-06 | 7 | 161 | 3 | 19063725 | |
| Pubmed | Increased proximal bifurcation of CA1 pyramidal apical dendrites in sema3A mutant mice. | 3.36e-06 | 7 | 161 | 3 | 19655386 | |
| Pubmed | A radial axis defined by semaphorin-to-neuropilin signaling controls pancreatic islet morphogenesis. | 4.37e-06 | 24 | 161 | 4 | 28893946 | |
| Pubmed | 5.36e-06 | 8 | 161 | 3 | 37591863 | ||
| Pubmed | 5.36e-06 | 8 | 161 | 3 | 28637841 | ||
| Pubmed | Integration of opposing semaphorin guidance cues in cortical axons. | 5.36e-06 | 8 | 161 | 3 | 22368082 | |
| Pubmed | 5.36e-06 | 8 | 161 | 3 | 18786357 | ||
| Pubmed | 8.31e-06 | 28 | 161 | 4 | 18617019 | ||
| Pubmed | Plexin A3 and plexin A4 convey semaphorin signals during facial nerve development. | 1.14e-05 | 10 | 161 | 3 | 18804103 | |
| Pubmed | On and off retinal circuit assembly by divergent molecular mechanisms. | 2.08e-05 | 12 | 161 | 3 | 24179230 | |
| Pubmed | 2.08e-05 | 12 | 161 | 3 | 23991118 | ||
| Pubmed | 2.08e-05 | 12 | 161 | 3 | 25839327 | ||
| Pubmed | 2.08e-05 | 12 | 161 | 3 | 31690636 | ||
| Pubmed | 2.08e-05 | 12 | 161 | 3 | 28407732 | ||
| Pubmed | Two new cases of interstitial 7q35q36.1 deletion including CNTNAP2 and KMT2C. | 2.13e-05 | 2 | 161 | 2 | 34582124 | |
| Pubmed | Chromosomal region 16p13: further evidence of increased predisposition to immune diseases. | 2.13e-05 | 2 | 161 | 2 | 19221398 | |
| Pubmed | Isolation and characterization of mammalian HDAC10, a novel histone deacetylase. | 2.13e-05 | 2 | 161 | 2 | 11677242 | |
| Pubmed | PTPRD and CNTNAP2 as markers of tumor aggressiveness in oligodendrogliomas. | 2.13e-05 | 2 | 161 | 2 | 35982066 | |
| Pubmed | Facilitation of Th1-mediated immune response by prostaglandin E receptor EP1. | 2.13e-05 | 2 | 161 | 2 | 17967902 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 19317741 | ||
| Pubmed | Histone deacetylase 10 structure and molecular function as a polyamine deacetylase. | 2.13e-05 | 2 | 161 | 2 | 28516954 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 9566880 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 24619647 | ||
| Pubmed | A census of human transcription factors: function, expression and evolution. | TFEC TBX3 CUX2 ETS2 RFX8 LHX6 PRDM2 OTP USF3 PAX8 GLI3 ZNF335 HEY2 NR3C2 FOXK1 | 2.29e-05 | 908 | 161 | 15 | 19274049 |
| Pubmed | 2.39e-05 | 251 | 161 | 8 | 29031500 | ||
| Pubmed | 2.69e-05 | 13 | 161 | 3 | 11604131 | ||
| Pubmed | Semaphorin3A, Neuropilin-1, and PlexinA1 are required for lymphatic valve formation. | 2.69e-05 | 13 | 161 | 3 | 22723296 | |
| Pubmed | Functional assembly of accessory optic system circuitry critical for compensatory eye movements. | 2.69e-05 | 13 | 161 | 3 | 25959730 | |
| Pubmed | PLXNA3 TBX3 CUX2 ETS2 ZNF318 ZBTB49 KMT2C OTP GLI3 NR3C2 RFPL3 PLXNA2 FOXK1 | 2.84e-05 | 709 | 161 | 13 | 22988430 | |
| Pubmed | A midline switch of receptor processing regulates commissural axon guidance in vertebrates. | 3.41e-05 | 14 | 161 | 3 | 20159958 | |
| Pubmed | The G protein-coupled receptor repertoires of human and mouse. | 3.41e-05 | 79 | 161 | 5 | 12679517 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | CUX2 ESS2 SPATA31E1 KDM5D USF3 SLC12A2 PIP4P1 ATF7IP2 IRF2BPL WNK2 | 3.47e-05 | 430 | 161 | 10 | 35044719 |
| Pubmed | 4.25e-05 | 15 | 161 | 3 | 25453830 | ||
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | 5.01e-05 | 544 | 161 | 11 | 28473536 | |
| Pubmed | Expression of the semaphorins Sema 3D and Sema 3F in the developing parathyroid and thymus. | 5.22e-05 | 16 | 161 | 3 | 18489001 | |
| Pubmed | TBX3 HBS1L FRAS1 PPP6R1 MADD TYK2 PARP4 SULF2 TCF25 IFT122 CLEC16A PLXNB1 | 5.45e-05 | 650 | 161 | 12 | 38777146 | |
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 27397516 | ||
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 17296555 | ||
| Pubmed | HDAC6 and microtubules are required for autophagic degradation of aggregated huntingtin. | 6.37e-05 | 3 | 161 | 2 | 16192271 | |
| Pubmed | LAR receptor phospho-tyrosine phosphatases regulate NMDA-receptor responses. | 6.37e-05 | 3 | 161 | 2 | 31985401 | |
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 20139422 | ||
| Pubmed | Intact synapse structure and function after combined knockout of PTPδ, PTPσ, and LAR. | 6.37e-05 | 3 | 161 | 2 | 33656439 | |
| Pubmed | Regulation of Tbx3 expression by anteroposterior signalling in vertebrate limb development. | 6.37e-05 | 3 | 161 | 2 | 12376101 | |
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 18523013 | ||
| Pubmed | Role of transmembrane semaphorin Sema6A in oligodendrocyte differentiation and myelination. | 6.37e-05 | 3 | 161 | 2 | 22777942 | |
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 8609418 | ||
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 11861901 | ||
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 23133532 | ||
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 8806646 | ||
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 18625214 | ||
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 9784606 | ||
| Pubmed | Differential expression of plexin-A subfamily members in the mouse nervous system. | 6.37e-05 | 3 | 161 | 2 | 11241833 | |
| Pubmed | Structural basis for LAR-RPTP/Slitrk complex-mediated synaptic adhesion. | 6.37e-05 | 3 | 161 | 2 | 25394468 | |
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 16461893 | ||
| Pubmed | TBX3 HDAC6 TAF1C ZNF318 PPP6R1 TRRAP TYK2 BPTF SULF2 PNPLA6 SLC16A1 GLI3 RTL9 TCF25 KIF18B FOXK1 | 6.60e-05 | 1116 | 161 | 16 | 31753913 | |
| Pubmed | 6.76e-05 | 47 | 161 | 4 | 35462405 | ||
| Pubmed | 6.92e-05 | 376 | 161 | 9 | 24154525 | ||
| Pubmed | 7.96e-05 | 152 | 161 | 6 | 34299191 | ||
| Pubmed | 9.06e-05 | 225 | 161 | 7 | 12168954 | ||
| Pubmed | 9.52e-05 | 157 | 161 | 6 | 30186101 | ||
| Pubmed | 1.01e-04 | 52 | 161 | 4 | 26633812 | ||
| Pubmed | 1.27e-04 | 4 | 161 | 2 | 25552398 | ||
| Pubmed | 1.27e-04 | 4 | 161 | 2 | 21493956 | ||
| Pubmed | 1.27e-04 | 4 | 161 | 2 | 34100078 | ||
| Pubmed | 1.27e-04 | 4 | 161 | 2 | 15721238 | ||
| Pubmed | 1.27e-04 | 4 | 161 | 2 | 20600896 | ||
| Pubmed | 1.27e-04 | 4 | 161 | 2 | 8524829 | ||
| Pubmed | Semaphorin-plexin signalling genes associated with human breast tumourigenesis. | 1.27e-04 | 4 | 161 | 2 | 21925246 | |
| Pubmed | 1.27e-04 | 4 | 161 | 2 | 20877282 | ||
| Pubmed | 1.27e-04 | 4 | 161 | 2 | 10725340 | ||
| Pubmed | 1.27e-04 | 4 | 161 | 2 | 21998580 | ||
| Pubmed | 1.27e-04 | 4 | 161 | 2 | 11937578 | ||
| Pubmed | CTCF Governs the Identity and Migration of MGE-Derived Cortical Interneurons. | 1.54e-04 | 58 | 161 | 4 | 30377227 | |
| Pubmed | 1.61e-04 | 23 | 161 | 3 | 38828908 | ||
| Pubmed | A semaphorin code defines subpopulations of spinal motor neurons during mouse development. | 1.83e-04 | 24 | 161 | 3 | 15869472 | |
| Pubmed | Loss of Gsx1 and Gsx2 function rescues distinct phenotypes in Dlx1/2 mutants. | 2.08e-04 | 25 | 161 | 3 | 23042297 | |
| Pubmed | 2.11e-04 | 5 | 161 | 2 | 22593055 | ||
| Pubmed | 2.11e-04 | 5 | 161 | 2 | 25313870 | ||
| Pubmed | 2.11e-04 | 5 | 161 | 2 | 10777529 | ||
| Pubmed | Deactylase inhibitors disrupt cellular complexes containing protein phosphatases and deacetylases. | 2.11e-04 | 5 | 161 | 2 | 14670976 | |
| Pubmed | 2.11e-04 | 5 | 161 | 2 | 23532979 | ||
| Pubmed | 2.11e-04 | 5 | 161 | 2 | 25054560 | ||
| Pubmed | 2.11e-04 | 5 | 161 | 2 | 22357843 | ||
| Pubmed | Cloning and expression of a cDNA for the human prostaglandin E receptor EP1 subtype. | 2.11e-04 | 5 | 161 | 2 | 8253813 | |
| Pubmed | Secreted semaphorins control spine distribution and morphogenesis in the postnatal CNS. | 3.16e-04 | 6 | 161 | 2 | 20010807 | |
| Pubmed | 3.16e-04 | 6 | 161 | 2 | 19273906 | ||
| Interaction | SEMA5B interactions | 4.53e-06 | 15 | 157 | 4 | int:SEMA5B | |
| Interaction | SEMA5A interactions | 1.59e-05 | 7 | 157 | 3 | int:SEMA5A | |
| GeneFamily | Plexins | 1.60e-07 | 9 | 110 | 4 | 683 | |
| GeneFamily | Protein phosphatase 1 regulatory subunits|Histone deacetylases, class IIB | 3.67e-05 | 2 | 110 | 2 | 993 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 1.28e-03 | 9 | 110 | 2 | 1230 | |
| GeneFamily | Patatin like phospholipase domain containing | 1.60e-03 | 10 | 110 | 2 | 466 | |
| GeneFamily | Maestro heat like repeat containing | 1.95e-03 | 11 | 110 | 2 | 636 | |
| GeneFamily | Fibronectin type III domain containing | 2.96e-03 | 160 | 110 | 5 | 555 | |
| GeneFamily | ATP binding cassette subfamily A | 3.18e-03 | 14 | 110 | 2 | 805 | |
| ToppCell | moderate-Myeloid-pDC|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.03e-08 | 180 | 161 | 9 | a0751ad5e42a21cb107d900abfa9ee967a0069fc | |
| ToppCell | NS-moderate-d_16-33-Myeloid-pDC|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.03e-08 | 180 | 161 | 9 | 144818e69613296cde43f29cb8c20899c670b319 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_naive-B_naive-1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.69e-08 | 131 | 161 | 8 | a3a086ce6e69707ca6a042f3b15c130f81909acb | |
| ToppCell | NS-critical-d_07-13-Myeloid-pDC|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.61e-07 | 165 | 161 | 8 | 17d5c4a111d9b5400780bc5e7b93ce2f5d69ceb7 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.61e-07 | 165 | 161 | 8 | fead3f2032f8fa5f7f0159a4434989b3d65debbb | |
| ToppCell | Mild/Remission-B_naive-4|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.93e-07 | 169 | 161 | 8 | c3a6179a64589a370108fea809b157839347759c | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.02e-07 | 170 | 161 | 8 | b49f7c8a27078de2137ed04f74cfee30729cfa5e | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.64e-07 | 176 | 161 | 8 | ad05dd934f4ac2e656b3455de091f4c8772de6c8 | |
| ToppCell | myeloid-Dendritic_cell-Plasmacytoid_dendritic_cell|myeloid / Lineage, cell class and subclass | 2.87e-07 | 178 | 161 | 8 | f75591988bbbeba073b66329a3437cb9b02f7648 | |
| ToppCell | normal_Lung-B_lymphocytes|normal_Lung / Location, Cell class and cell subclass | 3.00e-07 | 179 | 161 | 8 | 5b89193486100b6754c1c5eca3105ea955805eae | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Dendritic|bone_marrow / Manually curated celltypes from each tissue | 5.53e-07 | 194 | 161 | 8 | 768271ae45ff9f6aa3cd9b0ed15fa3caaa68a7b0 | |
| ToppCell | Biopsy_Control_(H.)-Immune-pDCs|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 5.74e-07 | 195 | 161 | 8 | 47d139215f0b51f5ea9b5fb09b1100e320e3f1e2 | |
| ToppCell | distal-3-Hematologic-Plasmacytoid_Dendritic|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.97e-07 | 196 | 161 | 8 | 6028b790abba9bad1d5373bab13eb24855988f48 | |
| ToppCell | distal-Hematologic-Plasmacytoid_Dendritic-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.20e-07 | 197 | 161 | 8 | 3a5908deb5c5a2bf06019a102fb1652233cf2a2a | |
| ToppCell | distal-Hematologic-Plasmacytoid_Dendritic|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.45e-07 | 198 | 161 | 8 | bb03744d8372405c278a0781e2f513bed00cf2b3 | |
| ToppCell | distal-2-Hematologic-Plasmacytoid_Dendritic|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.70e-07 | 199 | 161 | 8 | 78796b05d28b35e7361b6271d4a3858faa39c45c | |
| ToppCell | severe-B_naive|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.95e-07 | 200 | 161 | 8 | 0e86f52b6e146d9bbc728d8fb176fc2b53696558 | |
| ToppCell | mild-B_naive|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.95e-07 | 200 | 161 | 8 | 222789b897e2a683bbfd1d00b6fd8705015d90df | |
| ToppCell | Fetal_29-31_weeks-Immune-dendritic_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.26e-06 | 150 | 161 | 7 | 57f21ad380fd1350a2c25d75ad8c3b763ded53ec | |
| ToppCell | Severe-B_naive-1|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.86e-06 | 159 | 161 | 7 | 2881b054bbeb479221ee3c38bbd9b0815b123579 | |
| ToppCell | Children_(3_yrs)-Immune-dendritic_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.11e-06 | 162 | 161 | 7 | 86a0b9dabd150dc993bfc0f3344804de7f8e4042 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.69e-06 | 168 | 161 | 7 | 96f7411474edd673b8d3ee6b8a8bb185c246daaf | |
| ToppCell | metastatic_Brain-B_lymphocytes-GrB-secreting_B_cells|metastatic_Brain / Location, Cell class and cell subclass | 2.79e-06 | 169 | 161 | 7 | 71f6761b9927f352e0ccc221ca373319915f4184 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.91e-06 | 170 | 161 | 7 | 92e765ae0d3adb38d3b22fddb873fd5ccad3fd44 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.91e-06 | 170 | 161 | 7 | 9f8b215caa1afa3cd7104c06fca7cfd790640f66 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_dendritic-CD1c-positive_myeloid_dendritic_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.91e-06 | 170 | 161 | 7 | cc66ac6846c58be9493eb270644ee3ce0f86cfea | |
| ToppCell | CTRL-Lymphoid-pDC|Lymphoid / Disease state, Lineage and Cell class | 3.39e-06 | 174 | 161 | 7 | ff4315e9fad198cc323fc987deb8652da137cf98 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.79e-06 | 177 | 161 | 7 | 8887ff6341eb070bdaa890cc2cd7745f0cf1b0af | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.79e-06 | 177 | 161 | 7 | 507f06d31ab773099c9431b6f433899dc97b5566 | |
| ToppCell | NS-moderate-d_16-33-Lymphoid-B_cell|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.79e-06 | 177 | 161 | 7 | 320fd77c7c98e9305dcc34a168ec9d674539ed65 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.24e-06 | 180 | 161 | 7 | c54af6fb11484dacd3efa1f10a487376ff820a5e | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.24e-06 | 180 | 161 | 7 | 07ac979b21be2425294d9818c48b5a1e6f014c19 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.39e-06 | 181 | 161 | 7 | 7af469f5bcb9b1ab3f35b2758bf2afb87e8eba57 | |
| ToppCell | normal_Lung-B_lymphocytes-GrB-secreting_B_cells|normal_Lung / Location, Cell class and cell subclass | 4.72e-06 | 183 | 161 | 7 | c930b957d16f9b0904b6c424acd914532e5cc137 | |
| ToppCell | COVID-19-Fibroblasts-Adventitial_FB|COVID-19 / group, cell type (main and fine annotations) | 5.07e-06 | 185 | 161 | 7 | a5aebf2b9b05b550d021272731d68af9a6b1229d | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.26e-06 | 186 | 161 | 7 | 0096a61b1841784c913752b4f3639200446cc02c | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.26e-06 | 186 | 161 | 7 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.26e-06 | 186 | 161 | 7 | 6345777847960c71a2ba3ce5a49c72c34ebd0e73 | |
| ToppCell | moderate-Lymphoid-B_cell|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.26e-06 | 186 | 161 | 7 | fd2c4c3e8929ca5d64f6c5064e5f3d3d6ba07b5f | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.26e-06 | 186 | 161 | 7 | 9e159ad7289dcae2ec7ce655df746f46801b81d3 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.64e-06 | 188 | 161 | 7 | d8decd9b5967873ca8320c2f9f07365f163c777f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.64e-06 | 188 | 161 | 7 | 505b6b4277d7dea87aee27191d0acca67928b8e6 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.64e-06 | 188 | 161 | 7 | 1f820cb19eb0e15f0eb69d07e457072bbdad8ecb | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.84e-06 | 189 | 161 | 7 | 784ace2be87f2ecb19490f4974f63a559516e0eb | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.84e-06 | 189 | 161 | 7 | 37ecbd73408d462b47d7e5611f203143e08a2689 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.04e-06 | 190 | 161 | 7 | c44aae2e0d3cc84a187e12917fd8c2d7483f41d8 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D175|Adult / Lineage, Cell type, age group and donor | 6.04e-06 | 190 | 161 | 7 | 7dcca3469f3a3b70db0420cb94f7765f39492f06 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.04e-06 | 190 | 161 | 7 | 2de8e4cfeee350a9a76af749d6ce58d948c129b8 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.04e-06 | 190 | 161 | 7 | 07f21386ea6eb23416a537d2250e3042efe93fb0 | |
| ToppCell | 3'_v3-bone_marrow-Myeloid_Dendritic|bone_marrow / Manually curated celltypes from each tissue | 6.04e-06 | 190 | 161 | 7 | 6892c603037b61ef88d6ca01b7592dc0d347d63b | |
| ToppCell | COVID-19_Severe-pDC|COVID-19_Severe / disease group, cell group and cell class | 6.04e-06 | 190 | 161 | 7 | c5ab6b7492fb86aff3d2af3eb671c9f985ae4aeb | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.04e-06 | 190 | 161 | 7 | 705489ebbaf3d8e643498c3e507742114475fc55 | |
| ToppCell | BAL-Severe-Myeloid-pDC-pDC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.25e-06 | 191 | 161 | 7 | 989bf108c7f2c78dd7f14481570f1819673a5469 | |
| ToppCell | BAL-Severe-Myeloid-pDC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.25e-06 | 191 | 161 | 7 | 3e7fbe4af2c23b3b964becde843d2f088ad41c23 | |
| ToppCell | BAL-Severe-Myeloid-pDC-pDC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.25e-06 | 191 | 161 | 7 | bc2f3c4e71e3a55fe76ea03f45746329a8fc81da | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.25e-06 | 191 | 161 | 7 | f3158cedf67e3b90aa94ea1f61c72c33aaa2d5ba | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.25e-06 | 191 | 161 | 7 | a90c8ab2077e52bbc998457c85a1b9867f9c8c93 | |
| ToppCell | BAL-Severe-Myeloid-pDC-pDC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.47e-06 | 192 | 161 | 7 | d9ff2293358c8b031ba212021012e058014ff472 | |
| ToppCell | Severe_COVID-19-Myeloid-pDC|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 6.47e-06 | 192 | 161 | 7 | f79424c643a375dfe4579eff7ac1ba191e28a283 | |
| ToppCell | BAL-Severe-Myeloid-pDC-pDC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.47e-06 | 192 | 161 | 7 | 2e8611d65090e39f1a6e74c972288e7b68376d15 | |
| ToppCell | BAL-Severe-Myeloid-pDC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.47e-06 | 192 | 161 | 7 | 43569726df281eebe57499e0993b9fd9d36118c2 | |
| ToppCell | COVID_non-vent-Lymphocytic-B_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 6.69e-06 | 193 | 161 | 7 | 32d139f922cd19adc1cc1e0e9a828115be9945d6 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 6.69e-06 | 193 | 161 | 7 | 503a979328c68b096680b71359a26f02fafdff35 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.69e-06 | 193 | 161 | 7 | 261cafc167c86ab277be4ea7f08b0173e2dde26e | |
| ToppCell | COVID_non-vent-Lymphocytic-B_cell-|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 6.69e-06 | 193 | 161 | 7 | 91955c3773c9729a96e82f240f06b072367970d9 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_B-Naive_B_cells|lymph-node_spleen / Manually curated celltypes from each tissue | 6.92e-06 | 194 | 161 | 7 | 20967afbadb3cf80ba9f4d7ebda4e64389252e70 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic-B_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.92e-06 | 194 | 161 | 7 | ff661419b697aef51a53fdeac8d37d870d65f491 | |
| ToppCell | 10x5'-Liver-Myeloid_Dendritic|Liver / Manually curated celltypes from each tissue | 6.92e-06 | 194 | 161 | 7 | e6391bc7073831847c469ef0b0c437118e1f151f | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.16e-06 | 195 | 161 | 7 | ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2 | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Dendritic_cell-DC_plasmacytoid|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.16e-06 | 195 | 161 | 7 | fbc324c3435f32b9ca269d83333faecfe940d7fe | |
| ToppCell | COVID-19-Lymphoid-pDC|Lymphoid / Condition, Lineage and Cell class | 7.16e-06 | 195 | 161 | 7 | 4a7c080230ce6a79335ecbeadecb0177b2c13625 | |
| ToppCell | distal-Hematologic-Plasmacytoid_Dendritic-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.40e-06 | 196 | 161 | 7 | 170629b9ae82e9a911b93e8739dcd38176fbecb4 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.65e-06 | 197 | 161 | 7 | f7a8440d2b8b17d9726c6fe3dd383effbfebab13 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.65e-06 | 197 | 161 | 7 | 412cb5f37df57121ddd1492021445479c7cbccbf | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.65e-06 | 197 | 161 | 7 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | COVID-19_Mild-Lymphoid_B|COVID-19_Mild / Disease group, lineage and cell class | 7.65e-06 | 197 | 161 | 7 | ff25c0e184bd0f068014bc3f5eba3aee17511b87 | |
| ToppCell | Bronchial-10x5prime-Stromal-Mesofibroblastic-Mesothelia|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.65e-06 | 197 | 161 | 7 | 26888af95a7cc082a1f1218af35b1f07cb9436ed | |
| ToppCell | Bronchial-10x5prime-Stromal-Mesofibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.65e-06 | 197 | 161 | 7 | 438de7f0d35d81d5f5e41dcef7b2c54b6da03df4 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.65e-06 | 197 | 161 | 7 | 7cae4f3eabfebce101de7bb7defb17d6c5360b58 | |
| ToppCell | Biopsy_IPF-Immune-pDCs|Biopsy_IPF / Sample group, Lineage and Cell type | 7.91e-06 | 198 | 161 | 7 | aa8943e6796f619406056cf763b751fe9a9a3e0c | |
| ToppCell | Biopsy_Other_PF-Mesenchymal-Mesothelial_cells|Biopsy_Other_PF / Sample group, Lineage and Cell type | 7.91e-06 | 198 | 161 | 7 | 86736f01e61bf4961f060b24ee1f1f48340737dd | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Macroglial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.91e-06 | 198 | 161 | 7 | 731a90f7e68b19e387499d63e3979af78b503b0c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.91e-06 | 198 | 161 | 7 | 43a2ce64fa309bac89a44ea320e87ae2cc39f782 | |
| ToppCell | distal-1-mesenchymal-Mesothelial|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.17e-06 | 199 | 161 | 7 | 8dd5b411d2f1626830b77a1616cc3fb67dc59338 | |
| ToppCell | mild-B_memory|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.17e-06 | 199 | 161 | 7 | e6ac9a0959b0de2c6a99298feb7715aa80ade1dd | |
| ToppCell | distal-Hematologic-Plasmacytoid_Dendritic-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.45e-06 | 200 | 161 | 7 | ef42753c9fbe3770e3f415cd7ab412654d359edb | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-B-B_naive|COVID-19_Mild / Disease, condition lineage and cell class | 8.45e-06 | 200 | 161 | 7 | e6a43eff47195e1d39530ad49ad908fc06a8b038 | |
| ToppCell | Macroglial|World / cells hierarchy compared to all cells using T-Statistic | 8.45e-06 | 200 | 161 | 7 | e6935ad49216d2500c15c05cbc2b89402c65e838 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-B-B_naive|COVID-19_Severe / Disease, condition lineage and cell class | 8.45e-06 | 200 | 161 | 7 | 5ba9c541fa356d34f392a63274dcd7bfb844cbb6 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.45e-06 | 200 | 161 | 7 | 56f1f007ba8c9188a4b10e52744f1e50dc0f155a | |
| ToppCell | 390C-Endothelial_cells-Endothelial-A_(Artery)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 8.45e-06 | 200 | 161 | 7 | 50b8788494b744e0f0ec8c4d67a1c90ae09dca65 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-A_(Artery)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 8.45e-06 | 200 | 161 | 7 | f5f24273bee3259a4a3be99ba53b88defa1286c0 | |
| ToppCell | severe-B_naive|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.45e-06 | 200 | 161 | 7 | 306df1f498ac2188eaf9f2a8d002bb73bdb9642d | |
| ToppCell | mild-B_naive|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.45e-06 | 200 | 161 | 7 | d0467cab6a42bf780aa49046bf3231ca161dc144 | |
| ToppCell | droplet-Heart-nan-3m-Hematologic-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-05 | 140 | 161 | 6 | ab90f6f30d89761687f8836e3d327d143ce49ed4 | |
| ToppCell | control-Myeloid-Monocyte-derived_Macrophage|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.53e-05 | 146 | 161 | 6 | 69e9c1ec6eec1151290227902e75e77a4aecc8db | |
| ToppCell | Mild/Remission-B_naive-4|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.66e-05 | 148 | 161 | 6 | dd5e1bc02824e743e1c030a303e32f27a359a8ca | |
| ToppCell | LPS_only-Myeloid-Dendritic_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.66e-05 | 148 | 161 | 6 | cb9365663f9cba35d47b5dd9079f42e88b70d915 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.79e-05 | 150 | 161 | 6 | 53de595376a9fc92491dfd58ff25938b0bf79903 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.79e-05 | 150 | 161 | 6 | e4b40b3243ed26d0c46bf196ac06e148834e7ed2 | |
| Disease | Addison Disease | 8.09e-05 | 3 | 154 | 2 | C0001403 | |
| Disease | Chediak-Higashi syndrome (implicated_via_orthology) | 1.61e-04 | 4 | 154 | 2 | DOID:2935 (implicated_via_orthology) | |
| Disease | hippocampal volume | 1.76e-04 | 297 | 154 | 8 | EFO_0005035 | |
| Disease | Sarcosine measurement | 2.29e-04 | 23 | 154 | 3 | EFO_0021668 | |
| Disease | Hydronephrosis | 2.68e-04 | 5 | 154 | 2 | C0020295 | |
| Disease | Addison's disease (is_implicated_in) | 2.68e-04 | 5 | 154 | 2 | DOID:13774 (is_implicated_in) | |
| Disease | mental development measurement | 2.95e-04 | 25 | 154 | 3 | EFO_0008230 | |
| Disease | Colorectal Carcinoma | TFEC CSMD3 LIFR KMT2C PTPRD ABCA5 PAX8 PTPRS TK1 GLI3 NR3C2 DNAH8 | 3.32e-04 | 702 | 154 | 12 | C0009402 |
| Disease | Autistic Disorder | 4.60e-04 | 261 | 154 | 7 | C0004352 | |
| Disease | childhood trauma measurement, alcohol consumption measurement | 5.28e-04 | 71 | 154 | 4 | EFO_0007878, EFO_0007979 | |
| Disease | multiple sclerosis (is_implicated_in) | 5.87e-04 | 73 | 154 | 4 | DOID:2377 (is_implicated_in) | |
| Disease | waist-hip ratio | CUX2 FAM53A DUSP1 ZNF318 SP8 BPTF CMIP NRXN3 PTPRD CIITA PTPRS GLI3 NAV3 IFT122 CLEC16A HTT | 7.05e-04 | 1226 | 154 | 16 | EFO_0004343 |
| Disease | nasal disorder | 8.07e-04 | 35 | 154 | 3 | MONDO_0002436 | |
| Disease | Bladder Neoplasm | 8.59e-04 | 140 | 154 | 5 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 8.87e-04 | 141 | 154 | 5 | C0005684 | |
| Disease | choroid plexus volume measurement | 9.51e-04 | 9 | 154 | 2 | EFO_0010293 | |
| Disease | cognitive decline measurement | 1.07e-03 | 486 | 154 | 9 | EFO_0007710 | |
| Disease | IGF-1 measurement | 1.10e-03 | 488 | 154 | 9 | EFO_0004627 | |
| Disease | serum albumin measurement | HBS1L MADD HSPB9 FAM117A SLC12A2 CIITA ABCA5 RTL9 IRF2BPL DAGLA | 1.14e-03 | 592 | 154 | 10 | EFO_0004535 |
| Disease | nasopharyngeal neoplasm | 1.20e-03 | 151 | 154 | 5 | EFO_0004252 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.24e-03 | 152 | 154 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | brain connectivity measurement | 1.25e-03 | 400 | 154 | 8 | EFO_0005210 | |
| Disease | oral microbiome measurement | 1.38e-03 | 42 | 154 | 3 | EFO_0801229 | |
| Disease | transient cerebral ischemia (biomarker_via_orthology) | 1.43e-03 | 157 | 154 | 5 | DOID:224 (biomarker_via_orthology) | |
| Disease | Paranoia | 1.44e-03 | 11 | 154 | 2 | C1456784 | |
| Disease | endometrial adenocarcinoma (is_marker_for) | 1.44e-03 | 11 | 154 | 2 | DOID:2870 (is_marker_for) | |
| Disease | platelet aggregation | 1.68e-03 | 45 | 154 | 3 | GO_0070527 | |
| Disease | hematologic cancer (implicated_via_orthology) | 2.03e-03 | 13 | 154 | 2 | DOID:2531 (implicated_via_orthology) | |
| Disease | gamma-glutamylleucine measurement | 2.03e-03 | 13 | 154 | 2 | EFO_0021140 | |
| Disease | HOMA-B | 3.00e-03 | 55 | 154 | 3 | EFO_0004469 | |
| Disease | DiGeorge Syndrome | 3.10e-03 | 16 | 154 | 2 | C0012236 | |
| Disease | CONOTRUNCAL ANOMALY FACE SYNDROME | 3.10e-03 | 16 | 154 | 2 | C0795907 | |
| Disease | pro-hydroxy-pro measurement | 3.10e-03 | 16 | 154 | 2 | EFO_0021132 | |
| Disease | lysosomal storage disease (implicated_via_orthology) | 3.10e-03 | 16 | 154 | 2 | DOID:3211 (implicated_via_orthology) | |
| Disease | response to darapladib, Diarrhea | 3.10e-03 | 16 | 154 | 2 | EFO_0008395, HP_0002014 | |
| Disease | Shprintzen syndrome | 3.10e-03 | 16 | 154 | 2 | C0220704 | |
| Disease | Polydactyly | 3.35e-03 | 117 | 154 | 4 | C0152427 | |
| Disease | rheumatoid arthritis (is_implicated_in) | 3.49e-03 | 58 | 154 | 3 | DOID:7148 (is_implicated_in) | |
| Disease | androstenedione measurement, estrone measurement | 3.92e-03 | 18 | 154 | 2 | EFO_0007970, EFO_0007972 | |
| Disease | neuroimaging measurement, brain volume measurement | 4.00e-03 | 286 | 154 | 6 | EFO_0004346, EFO_0006930 | |
| Disease | pursuit maintenance gain measurement | 4.01e-03 | 123 | 154 | 4 | EFO_0008433 | |
| Disease | Malignant neoplasm of breast | TBX3 TICAM1 ETS2 ZNF318 GALNT16 SLC2A10 SULF2 PTPRD MROH7 HEY2 MAP3K13 RUSF1 PLXNB1 | 4.25e-03 | 1074 | 154 | 13 | C0006142 |
| Disease | diet measurement, body mass index | 4.83e-03 | 20 | 154 | 2 | EFO_0004340, EFO_0008111 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| STLMNILCGLCPPSD | 521 | Q8WWZ7 | |
| LSPTVLSMCREAPGS | 186 | Q9NXW9 | |
| MAAAATGSPLLLTPS | 136 | A0A1W2PQ73 | |
| LMGLAETPGCATLLP | 246 | Q8WV16 | |
| LNCMLTSLPNGSSVI | 741 | Q96N23 | |
| LDSDIPCTPLNTLFM | 91 | Q8NHU2 | |
| TLGALMPSLPSCLSN | 286 | P83436 | |
| MPSLPSCLSNGVERA | 291 | P83436 | |
| CLSNFTAPMGTVLSP | 721 | Q7Z407 | |
| PQGSSQCATMELGPL | 16 | P33076 | |
| DQIPMPFSSSSLSCL | 206 | P33076 | |
| LLEPGNLASSPSMSL | 261 | Q9C073 | |
| SLMSSEELCPTAGLP | 196 | Q9UKT5 | |
| PACSTMSIELGPQAD | 436 | Q8IY22 | |
| QELGLPCSSPAAMRL | 486 | A5YM72 | |
| SLTAVCGGSLMPLPD | 16 | Q9ULZ1 | |
| MGRSLDQTSPCPLVL | 681 | Q6XZF7 | |
| CLSPGSSEMSLQPDL | 566 | Q6UB98 | |
| TCSLPQGMAKPEDSL | 381 | O14529 | |
| SPVGCLSETPDSSNM | 656 | Q12830 | |
| CLAATSTLMSSPGSP | 486 | Q8N428 | |
| ISPPSCMTLILGSNE | 321 | Q68CQ1 | |
| DSGDPPLSSNMSLSL | 536 | Q9Y5G6 | |
| NLPMDSCVATKSLSP | 141 | Q06710 | |
| DCLSIFGSSPMPGTL | 91 | O60671 | |
| SETALACSPPMQCLS | 301 | Q6ZSG2 | |
| DSGDPPLSSNMSLSL | 536 | Q9Y5G5 | |
| TGDRLLAMPPNETCT | 516 | Q9Y450 | |
| MSSLLSPPIACQSPA | 356 | Q9HCC9 | |
| LLMTASDSGDPPLSS | 561 | Q9Y5G9 | |
| SALRMPSTGSVAPCV | 236 | Q9UBP5 | |
| MAGSPVFLCTLAPLN | 151 | P53985 | |
| SAPLLSRCVSMPGDI | 411 | Q8IY17 | |
| MDSPSNATVPCGFLL | 1 | Q8NH08 | |
| TSGLECSSCQPPLLM | 476 | Q86XX4 | |
| SLSSCNPPAMATSAE | 1026 | P10071 | |
| MASPSLPGSDCSQII | 1 | O43194 | |
| PSTPNMAAGQLCTEL | 3666 | Q8NEZ4 | |
| MTPRGFSCLLLPTSE | 1 | P0CJ73 | |
| RSLLPDASITMCPSC | 1196 | Q9HBG6 | |
| KEMCGSPAPLSSNSS | 16 | Q2Q1W2 | |
| SPLNMTSSVCSPAGI | 196 | P08235 | |
| LPTCMASAEQLLLAP | 356 | Q8WXG6 | |
| QSSDAFPLCLMLLSP | 96 | Q93015 | |
| LVSFAVPMDSGPSCL | 316 | O95528 | |
| LPSNLSPTAMTCCLT | 106 | Q9BQS6 | |
| SPTAMTCCLTPSGQL | 111 | Q9BQS6 | |
| PMTDTAPLLFTCSNL | 401 | Q8N3F9 | |
| SGSSAACPSLMPLLQ | 1516 | Q9BY66 | |
| SSGSQLCEDLLLMPT | 756 | P38570 | |
| MSPSPTALFCLGLCL | 1 | Q9HCN6 | |
| DASCPMLPTALVSLS | 501 | Q9H1B7 | |
| MFSLPLSLPLCEDTA | 1 | Q7Z2X4 | |
| MSEIVCVSPPSSNGL | 1001 | O75051 | |
| LLCDSPSQTGRQPVM | 1181 | P51805 | |
| ATEMTCQAPALALGP | 1091 | Q9HCM2 | |
| QSPALLTGSGVMCPS | 576 | O43157 | |
| LFSSCSPPGMVLDGS | 481 | Q9BUK6 | |
| MSPCGPLNLSLAGEA | 1 | P34995 | |
| MEKASASSCPAPLEG | 571 | Q8IVL0 | |
| GPLQGSSCLEMLSTS | 131 | Q6ZU69 | |
| GLLDSMCPASTPSVL | 216 | P15036 | |
| TRTPLICFLSMGSDP | 3906 | Q96JB1 | |
| LSMTSEAGLPCLSDQ | 1381 | Q9Y4C0 | |
| CPSTMKNPASLLFSL | 286 | P09848 | |
| TTRCLEGTAPPAMAQ | 11 | Q9UPM6 | |
| LSCPLDLTLFPMDTQ | 181 | P48167 | |
| MALPTARPLLGSCGT | 1 | Q13421 | |
| VLLDPSCSGSGMPSR | 36 | Q3KNT7 | |
| RLPMASALPEALCSQ | 1476 | Q9UKK3 | |
| PLSATCALFEVMSTP | 1196 | Q8NDA8 | |
| MSCINLPTVLPGSPS | 1 | P04183 | |
| LGPSAMQNCSTPLAL | 701 | Q86Y91 | |
| MAGAACEPVARPSLT | 1 | Q5VYS4 | |
| MASLSRPSLPSCLCS | 1 | Q16653 | |
| TATMLCAASGNPDPE | 151 | Q13332 | |
| LPGSSPDLISTAMAA | 691 | O43283 | |
| MSPQGPAVLSLGSLC | 1 | Q2TBC4 | |
| SDCTGLPLSMLTNPA | 371 | Q8N414 | |
| SMCSPVPLLAAASGQ | 6 | P0C5K6 | |
| METPGASASSLLLPA | 1 | Q96DF8 | |
| NLSLLAPCLSLGMSE | 2141 | P42858 | |
| GPMAPCQSALESIQS | 331 | Q969S8 | |
| DMGESCLLPPSGSTS | 426 | P24394 | |
| ILSDLPSLCSPAGCM | 1761 | Q9P2D3 | |
| AFCSLALSAPMGSDP | 16 | Q8NHW4 | |
| GDPLPTESRLMNSCL | 31 | O60609 | |
| SCPELCSKQSTPMGL | 131 | P28562 | |
| CSKQSTPMGLSLPLS | 136 | P28562 | |
| GLLSPPMATTCTSTA | 2536 | Q8TD26 | |
| LSMRTLSTPSPALIC | 46 | Q9UJT9 | |
| LASLSTLDLCGMTPV | 236 | Q8NCQ5 | |
| GSPVTLTCKMPFLQS | 31 | Q96LA6 | |
| GTLDSCIMKPSASLP | 281 | O60883 | |
| MRLPGCTLAASEAAP | 181 | Q9H972 | |
| PCMPQAASNTSLGLG | 26 | Q8TDV2 | |
| MVSGQCTLPGLSLLP | 181 | Q9HC77 | |
| SGVSPSPGSLMTLCL | 456 | Q2M3T9 | |
| MTTQVCCSPGLASPL | 131 | Q96LW7 | |
| LMSPRSGGLQTPECL | 426 | P85037 | |
| LTSAGILPVMQSLCP | 61 | Q9BZC7 | |
| PLPMACTLSQFLASN | 636 | Q5U623 | |
| MDLTPTGLSSQECLA | 1001 | Q9Y4D2 | |
| SNMALSSCLLLPGDA | 671 | Q92636 | |
| ALPAMPTARCSCSSL | 311 | Q8IXV7 | |
| SCMVENPISQGRSLP | 216 | Q14CZ8 | |
| ESNCGASPLTLSPMS | 1211 | Q9UHC6 | |
| SASLHTLLGDPCPML | 396 | Q9UBN7 | |
| RSSLPSQDAMLCSGP | 871 | P54198 | |
| MATSLTSPCPLHLGA | 226 | Q1HG43 | |
| MACGPGDLQSLTSPL | 1 | E5RG02 | |
| LSAGLLCPSGSNMPI | 71 | P09683 | |
| LTSPDSGSAPMITCR | 71 | Q86T03 | |
| TLDLSGCQLPAPMVT | 816 | P59044 | |
| GSSALKTLEMNPCTP | 891 | P42702 | |
| SSPPSLGPDCLIMNS | 446 | Q13029 | |
| SDPMVPSCSLSLPLS | 656 | Q13029 | |
| LSQCSLAAGPPPNSM | 236 | Q5XKR4 | |
| RTATMLCAASGNPDP | 141 | P23468 | |
| GSALMIETARNPTCP | 546 | Q9NP80 | |
| PCPSKSQMATRGLLD | 141 | Q8TC99 | |
| SLLMLPLVSGCPGFS | 246 | Q96GQ5 | |
| DSGALSPLLMPASDS | 96 | Q8NET4 | |
| MLRGAPDSAPAQVCT | 121 | Q6NUJ1 | |
| LTTALPSMAAAAGPL | 656 | O15119 | |
| PLGLSDVPDLSFMCS | 16 | Q15572 | |
| MTSPLCRAASANALP | 1 | A5D8V7 | |
| CMASRGLSLFPESCP | 31 | Q8N114 | |
| MSPGDPCSSRALQVL | 1006 | Q6ZUB1 | |
| SAPDACLTMSPNSVG | 916 | Q9P2P6 | |
| LVMSSPALPAFLLCS | 6 | O14684 | |
| MPSLLPLSCSDISRS | 181 | Q8NH09 | |
| AMSQIPAGGTDCSLP | 436 | P10155 | |
| LLSLDAQTGECSSMP | 136 | Q92935 | |
| MLAATCNKIGSPSPS | 1 | Q8IXZ3 | |
| MSPVPGSACTALAAA | 306 | Q8IZF4 | |
| EMSLLPTTCLSPTGR | 471 | Q6ZVT6 | |
| LTGMPPLSTPAAACT | 1021 | Q2KHT3 | |
| PRNMTGLDLAAVTCP | 116 | Q6ZS10 | |
| MAAPEQPLAISRGCT | 1 | Q96LT9 | |
| MSSLQALCSGLPLRP | 1 | Q96N76 | |
| TLPPFMCNTGATDLQ | 66 | Q7RTT3 | |
| MACTGPSLPSAFDIL | 1 | Q8IUC6 | |
| LSQACASPSMEPLGV | 481 | Q6ZV50 | |
| GCLLPQSQARPSSDM | 781 | Q5VZP5 | |
| CLVMTGAPNSRPALL | 791 | P55011 | |
| ESPGPSCTLMALQSI | 476 | Q6ZS81 | |
| SDVSMPILGPSLLFC | 396 | Q8TBZ2 | |
| LPDGSAMSPLLTIAN | 2201 | Q68DE3 | |
| LSICPLMNSGTTDAP | 296 | O75679 | |
| LPGLLCTISLQSGSM | 71 | Q9H777 | |
| CVSTMLSLGPPPDSS | 406 | Q9UPN7 | |
| QGSMLTPLSASDPLA | 86 | A8K0R7 | |
| LTSLGLSMPADPCEG | 251 | A8K0R7 | |
| IFMNGACSPSLLPTL | 401 | Q70CQ3 | |
| PINMGLTSASCPSSL | 106 | O14948 | |
| PGMPCNSTLSLQSTL | 126 | Q6ZSB9 | |
| MGQSLSVPASSCVLP | 401 | A2RRH5 | |
| MLGSLADAAPSPAQC | 636 | Q9Y3S1 | |
| ALPDPNMLVSDCTAS | 111 | Q9H4Z2 | |
| MLPPESPGLNNSISC | 431 | Q9NVE5 | |
| STPIGTSCQGAMLPS | 2506 | Q9Y4A5 | |
| SPARSAMCLTGSPQE | 1896 | Q5VUA4 | |
| TMFPGVLLPLLESCS | 456 | Q9BQ70 | |
| MGPPSLVLCLLSATV | 1 | Q8IWU5 | |
| ALMSSCLATAGPEPG | 11 | Q03167 | |
| PECLPGGANSLSTAM | 781 | P29597 | |
| LSSPCDSRGLPGITM | 321 | Q6NSI3 | |
| SGAMTSPNPLCSLLT | 441 | Q96NY9 |